LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer

Unlike other types of breast cancer, triple negative breast cancer (TNBC) does not respond to therapies targeting human epidermal growth factor receptor-2 (HER2) or hormone therapy, and the prognosis of patients with TNBC is usually poor. The role of long non-coding RNA (lncRNA) small nucleolar RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Aini, Shataer, Bolati, Shayiti, Ding, Wei, Liu, Siyin, Su, Pengcheng, Aili, Saiding, Naman, Yimin, Xuekelaiti, Kuerban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275935/
https://www.ncbi.nlm.nih.gov/pubmed/35506202
http://dx.doi.org/10.1080/21655979.2022.2063592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275935/
https://www.ncbi.nlm.nih.gov/pubmed/35506202
http://dx.doi.org/10.1080/21655979.2022.2063592

Ejemplares similares